ÈÕ²©¼¯ÍÅ

²úÆ·ÖÐÐÄ

ÁªÏµÈÕ²©¼¯ÍÅ

+86-010-82156767

ÏúÊÛרÓãº

+86-010-62983737 

+86-15522507305 

+86-15522507319 

+86-15522507326

µØµã£º±±¾©Êк£µíÇøÎ÷С¿Ú·66ºÅÖйش嶫Éý¿Æ¼¼Ô°C-1Â¥Èý²ã

³¤Ð§¶àëÄÖ¬·¾Ëá²àÁ´

ÒȸßѪÌÇËØÑùëÄ-1£¨Glucagon-like Peptide-1, GLP-1£©ÊÇÓÉÈ˳¦µÀÉøÍ¸µÄÒ»ÖÖëÄÀà¼¤ËØ£¬£¬£¬ £¬£¬Ëü¿É´Ì¼¤Òȵºβϸ°ûÉøÍ¸ÒȵºËØ£¬£¬£¬ £¬£¬¼ÓÈëÌåÄÚѪÌÇÆ½ºâµ÷Àí¡£¡£¡£¡£¡£GLP-1ÊÜÌ弤¶¯¼ÁÒѱ»ÆÕ±éÓ¦ÓÃÓÚ2ÐÍÌÇÄò²¡ºÍ·ÊÅÖµÄÖÎÁÆ¡£¡£¡£¡£¡£

ʹÓÃÖ¬·¾Ëá²àÁ´ÐÞÊÎÊÖÒÕ£¬£¬£¬ £¬£¬¿ÉʵÏÖGLP-1ÀàËÆÎïµÄ³¤Ð§»¯£¬£¬£¬ £¬£¬¼«´óÌá¸ß»¼ÕßÒÀ´ÓÐÔ¡£¡£¡£¡£¡£Ö¬·¾ËáÄܹ»ÒÔ¿ÉÄæµÄ·½·¨ÓëѪ½¬°×ÂѰף¨human serum albumin£¬£¬£¬ £¬£¬HSA£©Á¬Ïµ£¬£¬£¬ £¬£¬±£»£»£» £»£»£»¤¶àëÄÃâÊÜDPP-IV ½µ½âºÍÉö¹ýÂË£¬£¬£¬ £¬£¬´Ó¶øÑÓÉìÒ©Îï°ëË¥ÆÚ¡£¡£¡£¡£¡£

ÏÖÔÚÊг¡Ö÷Á÷³¤Ð§GLP-1ÊÜÌ弤¶¯¼Á£¬£¬£¬ £¬£¬ÈçÀûÀ­Â³ëÄ£¨Liraglutide£©¡¢Ë¾ÃÀ¸ñ³ëÄ£¨Semaglutide£© ºÍÌæ¶û²´ëÄ£¨Tirzepatide£©,¾ù½ÓÄÉÖ¬·¾Ëá²àÁ´ÐÞÊÎÊÖÒÕ¡£¡£¡£¡£¡£

 

Fig 1˾ÃÀ¸ñ³ëĺÍÌæ¶û²´ëĽṹ

Fig 1 The Structure of Semaglutide and Tirzepatide

ÈÕ²©¼¯ÍſƼ¼¿ÉÌṩʵÑéÊÒ¼°GMP¼¶±ðµÄ¸ßƱðÀ묷¾Ëá²àÁ´²úÆ·£¬£¬£¬ £¬£¬Æä׿ԽµÄ´¿¶ÈºÍ´ó¹æÄ£µÄÉú²úÄÜÁ¦£¬£¬£¬ £¬£¬È·±£Á˲úÆ·µÄÒ»ÖÂÐԺͿɿ¿ÐÔ£¬£¬£¬ £¬£¬µ¥Åú´Î²úÁ¿¿ÉµÖ´ï10¹«½ï£¬£¬£¬ £¬£¬²¢¿ÉÀ©Õ¹ÖÁ100¹«½ï£¬£¬£¬ £¬£¬Öª×ãÄú´ÓÔçÆÚÒ©ÎïÑз¢µ½ÉÌÒµ»¯Éú²úÈ«Á÷³ÌµÄÐèÇ󡣡£¡£¡£¡£

¹«Ë¾³Ð¼ÌÒÔÖÊÁÏÁ¢ÒìÒýÁìÉúÎïÒ½Ò©Á¢ÒìµÄ×ÚÖ¼£¬£¬£¬ £¬£¬×¢ÖØÊÖÒÕÑз¢£¬£¬£¬ £¬£¬ÈçÄúÐèÒªÆäËüδÁгöµÄ½á¹¹£¬£¬£¬ £¬£¬½Ó´ýÄúÀ´µç×Éѯ£¬£¬£¬ £¬£¬ÈÕ²©¼¯ÍſƼ¼¿ÉÌṩ²àÁ´Àà²úÆ·µÄ¶¨ÖƺϳÉЧÀÍ£¬£¬£¬ £¬£¬ÎªÄúµÄÑз¢ÏîÄ¿ÌṩÖÜȫ֧³Ö¡£¡£¡£¡£¡£

ÐòºÅ

Æ·Ãû

´úºÅ

½á¹¹Ê½

´¿¶È

+

tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu

¡Ý98%

OH-Ste-Glu(AEEA-AEEA-OSu)-OH

¡Ý90%

tBuO-Ste-Glu(AEEA-AEEA-OSu)-OtBu

¡Ý95%

Fmoc-Lys(tBuO-Ste-Glu(AEEA-AEEA)-OtBu)-OH

¡Ý98%

tBuO-ICO-Glu(AEEA-AEEA-OH)-OtBu

¡Ý98%

OH-ICO-Glu(AEEA-AEEA-OSu)-OH

¡Ý90%

tBuO-ICO-Glu(AEEA-AEEA-OSu)-OtBu

¡Ý95%

Fmoc-Lys(tBuO-ICO-Glu(AEEA-AEEA)-OtBu)-OH

¡Ý98%

< 1 > ǰÍù Ò³
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿